Literature DB >> 33156

Long term treatment of tardive dyskinesia.

A Jus, K Jus, P Fontaine.   

Abstract

A 4 year trial to treat tardive dyskinesia by a very slow progressive stepwise diminution of the neuroleptic dose and of antiparkinsonian agents as well as by administration of small, slowly increasing and then decreasing doses of reserpine or haloperidol was conducted on 62 chronic schizophrenic patients. This treatment program caused disappearance of tardive dyskinesia in 23, improvement in 26 patients and had no effect in 13 patients. The group of patients with disappearance of tardive dyskinesia had a mean age significantly lower than other groups. The rationale of this treatment was based on the concept of "desensitization" by a slow, progressive unblocking of dopaminergic receptor sites. Another tardive neuroleptic side effect, the "rabbit syndrome" was successfully treated in 7 other patients by antiparkinsonian drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 33156

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

1.  Rabbit syndrome after taking herbicide containing 2-(4-chloro2-methylphenoxypropionic) acid.

Authors:  Takeshi Kitamoto; Yoshito Kamijo
Journal:  Acute Med Surg       Date:  2015-09-22

2.  Study of behavioral factors associated with psychiatric rehospitalization.

Authors:  M A Morell; M Levine; D V Perkins
Journal:  Community Ment Health J       Date:  1982

Review 3.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

4.  Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose.

Authors:  M F Egan; T M Hyde; J E Kleinman; R J Wyatt
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

Review 5.  Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.

Authors:  Hanna Bergman; John Rathbone; Vivek Agarwal; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.